Atezolizumab, Rituximab, Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory DLBCL Not Suitable for High-dose Therapy
Clinical trial NCT03422523 · TERMINATED
Trial details
- NCT number
- NCT03422523
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-09
- Primary completion
- 2021-01-31
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.